PR
ZYME icon

PSP Research’s Zymeworks ZYME Stock Holding History

PSP Research’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Hold
10,000
– – 0.14% 54
2026
Q1 		$250K Sell
10,000
-10,312
-51% -$244K 0.18% 63
2025
Q4 		$535K Buy
+20,312
New +$443K 0.47% 29

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PSP Research's ZYME Position: Q2 2026 in Review

PSP Research held its Zymeworks (ZYME) position steady in Q2 2026 at 10,000 shares worth $261K. The position accounts for 0.14% of the portfolio, ranked #54.

PSP Research first reported a position in ZYME in Q4 2025 and has held it in 3 quarters since. The position peaked at $535K in Q4 2025. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • PSP Research held 10,000 shares of Zymeworks worth $261K as of Q2 2026.
  • PSP Research left its Zymeworks share count unchanged in Q2 2026.
  • Zymeworks made up 0.14% of PSP Research's portfolio in Q2 2026, its #54 holding.
  • PSP Research first reported a position in Zymeworks in Q4 2025 and has held it in 3 quarters since.
  • PSP Research's Zymeworks position peaked at $535K in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on PSP Research's 13F filing for Q2 2026, filed 9 Jul 2026.